{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:53:12Z","timestamp":1792291992000,"version":"4.4.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bioorg.2019.103291","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T01:47:10Z","timestamp":1568857630000},"page":"103291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"special_numbering":"C","title":["Recent advances in the synthetic and medicinal perspective of quinolones: A review"],"prefix":"10.1016","volume":"92","author":[{"given":"Prashant","family":"Dhiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punniyakoti Veeraveedu","family":"Thanikachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103291_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.18596\/jotcsa.55734","article-title":"Synthesis of novel fluoroquinolone-triazole hybrid compounds as antimicrobial agents","volume":"3","author":"\u00d6zdemir","year":"2016","journal-title":"J. Turkish Chem. Soc., Sect. A: Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0015","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"Overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"Weinstein","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103291_b0020","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.3390\/ijms140816570","article-title":"Development of quorum-based anti-virulence therapeutics targeting gram-negative bacterial pathogens","volume":"8","author":"Tay","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.103291_b0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jgar.2017.06.011","article-title":"Resistance to quinolones, cephalosporins and macrolides in escherichia coli causing bacteraemia in peruvian children","volume":"11","author":"Palma","year":"2017","journal-title":"J. Global Antimicrob. Resist."},{"key":"10.1016\/j.bioorg.2019.103291_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1473-3099(18)30708-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in switzerland","volume":"19","author":"Gasser","year":"2019","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.bioorg.2019.103291_b0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7015-12-96","article-title":"Outpatient antibiotic prescribing in the united states: 2000 to 2010","volume":"12","author":"Lee","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2019.103291_b0040","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against gram positive pathogens","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0045","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cdiscovery story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.inoche.2011.10.037","article-title":"DNA interaction and in-vitro antibacterial studies of fluoroquinolone based platinum(II) complexes","volume":"15","author":"Patel","year":"2012","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.103291_b0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1081\/JLC-100101698","article-title":"Sodium borohydride and hydrogen peroxide as fluorogenic spray reagents for the detection of nalidixic acid and flumequine","volume":"22","author":"Wang","year":"1999","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.bioorg.2019.103291_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000154","article-title":"Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review","volume":"4","author":"Sidhu","year":"2017","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.bioorg.2019.103291_b0065","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cmdc.201700426","article-title":"Synthesis and microbiological evaluation of novel tetracyclic fluoroquinolones","volume":"12","author":"Wagman","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.103291_b0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijantimicag.2010.12.014","article-title":"Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium","volume":"37","author":"Sano","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2019.103291_b0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138955706776361493","article-title":"Structural features of new quinolones and relationship to antibacterial activity against gram-positive bacteria","volume":"6","author":"Emami","year":"2006","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.bioorg.2019.103291_b0085","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2019.103291_b0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.bioorg.2019.103291_b0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0966-842X(93)90138-H","article-title":"On the mechanism of action of quinolone drugs","volume":"1","author":"Palumbo","year":"1993","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bioorg.2019.103291_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-6976.2010.00247.x","article-title":"Quinolones: from antibiotics to autoinducers","volume":"35","author":"Heeb","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2019.103291_b0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1039\/B612168N","article-title":"Quinoline, quinazoline and acridone alkaloids","volume":"25","author":"Michael","year":"2008","journal-title":"Nat. Prod. Report"},{"key":"10.1016\/j.bioorg.2019.103291_b0110","doi-asserted-by":"crossref","unstructured":"Pharmaceutical Nanotechnology United States Patent Watch (October to December 2016), Pharm. Nanotechnol. 5 (2017) 76\u201379. https:\/\/doi.org\/10.2174\/221173850501170316201812.","DOI":"10.2174\/221173850501170316201812"},{"key":"10.1016\/j.bioorg.2019.103291_b0115","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.bmcl.2009.05.091","article-title":"Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase","volume":"19","author":"Shaw","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0120","doi-asserted-by":"crossref","DOI":"10.1515\/zna-1982-1111","article-title":"Semiempirical mndo and uv absorption studies on tautomerism of 2-quinolones","volume":"37","author":"Mirek","year":"1982","journal-title":"Zeitschrift F\u00fcr Naturforschung A"},{"key":"10.1016\/j.bioorg.2019.103291_b0125","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/jo00018a020","article-title":"Lewis acid catalysis of photochemical reactions. 10. Spectroscopy and photochemistry of 2-quinolones and their Lewis acid complexes","volume":"56","author":"Lewis","year":"1991","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1039\/C8QO00884A","article-title":"Structural assignment of the enol\u2013keto tautomers of one-pot synthesized 4-hydroxyquinolines\/4-quinolones","volume":"6","author":"Kang","year":"2019","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.bioorg.2019.103291_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3987\/REV-14-806","article-title":"Synthesis, biological activities, and tautomerism of 4-quinolones and related compounds","volume":"91","author":"Kurasawa","year":"2015","journal-title":"Heterocycles"},{"key":"10.1016\/j.bioorg.2019.103291_h0140","doi-asserted-by":"crossref","first-page":"37797","DOI":"10.1021\/acsami.8b09946","article-title":"Cascade cytosol delivery of dual-sensitive micelle-tailored vaccine for enhancing cancer immunotherapy","volume":"10","author":"Jiang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2019.103291_h0145","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/jhet.3304","article-title":"synthesis, antioxidant, and antibacterial activities of some new 2-(3-fluorobenzyl)-1h-benzimidazole derivatives","volume":"55","author":"Bektas","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ardp.201200296","article-title":"Design and synthesis of aza-flavones as a new class of xanthine oxidase inhibitors","volume":"346","author":"Dhiman","year":"2013","journal-title":"Archiv. Pharm.-Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2019.103291_b0150","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3987\/COM-12-12523","article-title":"Novel heterocyclic derivatives of 2-quinolinone associated with antibacterial and antitumor potencies","volume":"85","author":"Hassanin","year":"2012","journal-title":"Heterocycles"},{"key":"10.1016\/j.bioorg.2019.103291_b0155","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1021\/jm900650s","article-title":"Corrections to rational modification of a candidate cancer drug for use against chagas disease","volume":"52","author":"Kraus","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0160","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.bmcl.2008.05.065","article-title":"Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives","volume":"18","author":"Cheng","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejmech.2010.11.019","article-title":"Structure\u2013activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents","volume":"46","author":"Guo","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bmc.2010.11.045","article-title":"Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid","volume":"19","author":"Curreli","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0175","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/jm5005978","article-title":"4-Aminoquinolone piperidine amides: noncovalent inhibitors of dpre1 with long residence time and potent antimycobacterial activity","volume":"57","author":"Naik","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bioorg.2017.09.015","article-title":"Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N -cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors","volume":"75","author":"Sekgota","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0185","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2174\/1389557511009011046","article-title":"Development of integrase inhibitors of quinolone acid derivatives for treatment of aids: an overview","volume":"10","author":"Luo","year":"2010","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0190","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1021\/jm9013136","article-title":"Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-chagas disease drug discovery","volume":"53","author":"Kraus","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0195","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1002\/anie.201501394","article-title":"LP99: discovery and synthesis of the first selective brd7\/9 bromodomain inhibitor","volume":"54","author":"Clark","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103291_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: an overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.actatropica.2018.12.036","article-title":"In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species","volume":"191","author":"Tavares","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2019.103291_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/tpd.2013.01","article-title":"Investigation of in vitro antileishmanial activity of moxifloxacin, linezolid and caspofungin on leishmania tropica promastigotes","volume":"37","author":"Limoncu","year":"2013","journal-title":"Turkish J. Parasitol."},{"key":"10.1016\/j.bioorg.2019.103291_b0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/acsmedchemlett.7b00545","article-title":"Synthesis and biological screening of pyrano[3,2-c]quinoline analogues as anti-inflammatory and anticancer agents","volume":"9","author":"Upadhyay","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1600-0609.2003.11213.x","article-title":"Farnesyltransferase inhibitor FTI-R115777 is well tolerat ed, induces stabilization of disease, and inhibits farnesylation and oncogenic\/tumor survival pathways in patients with advanced multiple myeloma","volume":"70","author":"Alsina","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bioorg.2019.103291_b0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2018.02.083","article-title":"The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimers disease","volume":"150","author":"Hepnarova","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0235","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ardp.201500115","article-title":"Synthesis and anticonvulsant activity evaluation of 4-phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4h)-one and its derivatives","volume":"348","author":"Zhang","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.103291_b0240","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1078-0432.CCR-08-2658","article-title":"Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage iib-iiic breast cancer","volume":"15","author":"Sparano","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0245","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.bmcl.2006.03.059","article-title":"4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors","volume":"16","author":"Ni","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0250","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3762\/bjoc.14.234","article-title":"Gold-catalyzed post-Ugi alkyne hydroarylation for the synthesis of 2-quinolones","volume":"14","author":"Du","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0255","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3762\/bjoc.9.304","article-title":"An efficient method for the construction of polysubstituted 4-pyridones via self-condensation of \u03b2-keto amides mediated by P2O5and catalyzed by zinc bromide","volume":"9","author":"Tan","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0260","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.bmcl.2016.02.037","article-title":"Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety","volume":"26","author":"Tang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0265","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/jm900173b","article-title":"Discovery of inducible nitric oxide synthase (inos) inhibitor development candidate kd7332, part 1: identification of a novel, potent, and selective series of quinolinone inos dimerization inhibitors that are orally active in rodent pain models","volume":"52","author":"Bonnefous","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2015.04.034","article-title":"New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno\u2013modulatory activity","volume":"97","author":"Manera","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0275","first-page":"11317","article-title":"Synthesis, characterisation, antioxidant and anticancer evaluation of novel schiff\u02cas bases of 2-quinolones","volume":"52","author":"Jayashree","year":"2012","journal-title":"Elixir Online J."},{"key":"10.1016\/j.bioorg.2019.103291_b0280","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/om101180c","article-title":"Physicochemical studies and anticancer potency of ruthenium \u03b76-p-cymene complexes containing antibacterial quinolones","volume":"30","author":"Kljun","year":"2011","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2019.103291_b0285","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"\u201cDesign, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of alzheimer\u2019s disease","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s10593-007-0136-4","article-title":"4-Hydroxy-2-quinolones 121. Synthesis and biological properties of 1-hydroxy-3-oxo-5,6-dihydro-3h-pyrrolo[3,2,1-ij]quino-line-2-carboxylic acid alkylamides","volume":"43","author":"Ukrainets","year":"2007","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2019.103291_b0295","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/AAC.33.10.1655","article-title":"Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis","volume":"33","author":"Wolfson","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2005","key":"10.1016\/j.bioorg.2019.103291_b0300","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Bambeke","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2019.103291_b0305","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1021\/jm100828n","volume":"53","author":"Payne","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0310","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bmcl.2011.11.073","article-title":"Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors","volume":"22","author":"Dur\u00f3n","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0315","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jpba.2007.07.021","article-title":"Determination of caderofloxacin lactate in rat plasma by high-performance liquid chromatography\u2013mass spectrometry and its application in rat pharmacokinetic studies","volume":"45","author":"Liu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2019.103291_b0320","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11095-012-0890-6","article-title":"effect of the fluoroquinolone antibacterial agent dx-619 on the apparent formation and renal clearances of 6\u03b2-hydroxycortisol, an endogenous probe for cyp3a4 inhibition, in healthy subjects","volume":"30","author":"Imamura","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.01311-05","article-title":"antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound","volume":"51","author":"Butler","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2019.103291_b0330","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/AAC.39.10.2183","article-title":"In vivo therapeutic efficacies of PD 138312 and PD 140248, two novel fluoronaphthyridines with outstanding gram-positive potency","volume":"39","author":"Shapiro","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103291_b0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bmc.2018.11.035","article-title":"Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0340","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.bmcl.2016.03.106","article-title":"Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases","volume":"26","author":"Miles","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0345","doi-asserted-by":"crossref","DOI":"10.4172\/1989-8436.100061","article-title":"Mode of action of mcb3681 in staphylococcus aureus\u2013 a proteomic study","volume":"07","author":"Voigt","year":"2016","journal-title":"Arch. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2019.103291_b0350","article-title":"In vitro activities of mcb3681 and eight comparators against clostridium difficile isolates with known ribotypes and diverse geographical spread","volume":"61","author":"Freeman","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0355","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dki361","article-title":"Activity of the new quinolones WCK 771, WCK 1152 and WCK 1153 against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes","volume":"56","author":"Al-Lahham","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0360","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/AAC.01651-07","article-title":"In vitro evaluation of cbr-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci, antimicrobial agents and chemotherapy","volume":"52","author":"Robertson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0365","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diagmicrobio.2008.05.010","article-title":"Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains","volume":"62","author":"Jones","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103291_b0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijantimicag.2010.02.022","article-title":"DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae","volume":"36","author":"Park","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2019.103291_b0375","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jmii.2015.09.005","article-title":"A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia","volume":"50","author":"Liu","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.bioorg.2019.103291_b0380","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/13543784.2012.699038","article-title":"Vosaroxin: a novel antineoplastic quinolone","volume":"21","author":"Abbas","year":"2012","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2019.103291_b0385","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S1470-2045(15)00165-5","article-title":"Vosaroxin in acute myeloid leukaemia","volume":"16","author":"Bornh\u00e4user","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioorg.2019.103291_b0390","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2014-10-608117","article-title":"Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia","volume":"125","author":"Dennis","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2019.103291_b0395","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2174\/138161212799958396","article-title":"Recent developments in the chemistry and biology of g-quadruplexes with reference to the dna groove binders","volume":"18","author":"Jain","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2019.103291_b0400","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jac\/dkx543","article-title":"Clinical review of delafloxacin: a novel anionic fluoroquinolone","volume":"73","author":"Mogle","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0405","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/13543784.2015.1005205","article-title":"Delafloxacin for the treatment of respiratory and skin infections","volume":"24","author":"Bassetti","year":"2015","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2019.103291_b0410","doi-asserted-by":"crossref","unstructured":"Radiolabeling, biological evaluation and molecular docking of delafloxacin: a novel methicillin-resistant Staphylococcus aureus infection radiotracer, J. Radioanal. Nucl. Chem. 306 (2015) 123\u2013130. https:\/\/doi.org\/10.1007\/s10967-015-4069-6.","DOI":"10.1007\/s10967-015-4069-6"},{"key":"10.1016\/j.bioorg.2019.103291_b0415","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01348-18","article-title":"In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against mycoplasmas and ureaplasmas in humans, including isolates with defined resistance mechanisms","volume":"62","author":"Xue","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0420","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw172.1374","article-title":"Activity of pexiganan when tested against contemporary gram-positive and gram-negative bacteria collected from North America, Europe and Japan","volume":"3","author":"Flamm","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103291_b0425","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543784.2017.1304538","article-title":"Cadazolid for the treatment of Clostridium difficile","volume":"26","author":"Endres","year":"2017","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2019.103291_b0430","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1128\/AAC.00504-15","article-title":"Multicenter, Double-blind, randomized, phase 2 study evaluating the novel antibiotic cadazolid in patients with clostridium difficile infection","volume":"59","author":"Louie","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2019.103291_b0435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/2211352516666180215151216","article-title":"Recent advances of 2-Quinolone-based derivatives as anti-tubercular agents","volume":"16","author":"Liu","year":"2018","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.bioorg.2019.103291_b0440","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/jhet.3244","article-title":"4-Quinolone derivatives and their activities against gram-negative pathogens","volume":"55","author":"Jiang","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0445","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anticancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0450","first-page":"1","article-title":"Recent updates of fluoroquinolones as antibacterial agents","volume":"351","author":"Ezerlarab","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.103291_b0455","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone derivatives and their antitubercular activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: an overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0465","article-title":"Current trends and future directions of fluoroquinolones","author":"Mohammed","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0470","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluroquinolone-isatin hybrids and their biological activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0475","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules21040268","article-title":"The current case of quinolones: synthetic approaches and antibacterial activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103291_b0480","article-title":"Microwave assisted synthesis of 4-quinolones and N, N\u2032-diarylureas","volume":"2","author":"Duarte","year":"2013","journal-title":"Green Process. Synth."},{"key":"10.1016\/j.bioorg.2019.103291_h0490","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/ol902626d","article-title":"Palladium-catalyzed tandem amination reaction for the synthesis of 4-quinolones","volume":"12","author":"Zhao","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_h0495","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1055\/s-0031-1290775","article-title":"Synthesis of N-alkyl substituted 4-quinolones via tandem alkenyl and aryl C-N bond formation","volume":"44","author":"Shao","year":"2012","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2019.103291_b0490","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1021\/acs.orglett.7b02495","article-title":"Direct synthesis of 4-quinolones via copper-catalyzed anilines and alkynes","volume":"19","author":"Xu","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0495","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/acs.orglett.8b00436","article-title":"Divergent synthesis of quinolones and dihydroepindolidiones via cu(I)-catalyzed cyclization of anilines with alkynes","volume":"20","author":"Xu","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0500","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/2213335601666140402002204","article-title":"Microwave assisted synthesis of ethyl-quinolon-4-one-3-carboxylates and hydrolysis to quinolon-4-one-3-carboxylic acids","volume":"1","author":"Malvacio","year":"2014","journal-title":"Curr. Microwave Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0505","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.orglett.8b01645","article-title":"Switchable access to 3-carboxylate-4-quinolones and 1-vinyl-3-carboxylate-4-quinolones via oxidative cyclization of isatins and alkynes","volume":"20","author":"Jiang","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0510","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.tetlet.2018.04.029","article-title":"Carbonylative sonogashira annulation sequence: one-pot synthesis of 4-quinolone and 4H-chromen-4-one derivatives","volume":"59","author":"Ghosh","year":"2018","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0515","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1021\/acs.orglett.7b03337","article-title":"From ketones, amines, and carbon monoxide to 4-quinolones: palladium-catalyzed oxidative carbonylation","volume":"19","author":"Wu","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0520","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/jo502400h","article-title":"Synthesis of 4-quinolones via a carbonylative sonogashira cross-coupling using molybdenum hexacarbonyl as a co source","volume":"80","author":"\u00c5kerbladh","year":"2015","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0525","first-page":"181","article-title":"Iron (III) phosphate catalyzed the synthesis of 4-quinolones","volume":"2","author":"Samadi","year":"2018","journal-title":"Chem. Methodol."},{"key":"10.1016\/j.bioorg.2019.103291_b0530","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ajoc.201800036","article-title":"visible light-induced aerobic oxidation of indoles: one-pot formation of 4-quinolones at room temperature","volume":"7","author":"Ji","year":"2018","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0535","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/acs.orglett.7b00968","article-title":"Co(III)-catalyzed enaminone-directed c\u2013h amidation for quinolone synthesis","volume":"19","author":"Shi","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0540","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1039\/C6RA28631C","article-title":"Efficient synthesis of novel N-substituted 2-carboxy-4-quinolones via lithium bis(trimethylsilyl)amide (LiHMDS)-induced in situ cyclocondensation reaction","volume":"7","author":"Hasan","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.103291_b0545","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/jacs.8b01561","article-title":"Visible-light-driven alkyne hydro-\/carbocarboxylation using co2 via iridium\/cobalt dual catalysis for divergent heterocycle synthesis","volume":"140","author":"Hou","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103291_b0550","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/jo202427m","article-title":"4-Aryl-2-quinolones from 3,3-diarylacrylamides through intramolecular copper-catalyzed C-H functionalization\/C\u2013N bond formation","volume":"77","author":"Berrino","year":"2012","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0555","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acs.joc.6b02984","article-title":"Gold-catalyzed hydroarylation of N-aryl alkynamides for the synthesis of 2-quinolinones","volume":"82","author":"Vacala","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0560","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1055\/s-0036-1590821","article-title":"Triflic anhydride promoted intramolecular cyclization of N-aryl cinnamides: access to polysubstituted quinolin-2(1H)-ones","volume":"49","author":"Zhang","year":"2017","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2019.103291_b0565","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1055\/s-0034-1380751","article-title":"Synthesis of 2-quinolinones through palladium(II) acetate catalyzed cyclization of N-(2-formylaryl)alkynamides","volume":"26","author":"Zhang","year":"2015","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2019.103291_b0570","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1021\/acs.joc.7b01932","article-title":"A mild rhodium catalyzed direct synthesis of quinolones from pyridones: application in the detection of nitroaromatics","volume":"82","author":"Biswas","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0575","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ol303546p","article-title":"Synthesis of quinolones by nickel-catalyzed cycloaddition via elimination of nitrile","volume":"15","author":"Nakai","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0580","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.tet.2019.03.026","article-title":"Cationic Pd(II) catalyzed regioselective intramolecular hydroarylation for the efficient synthesis of 4-aryl-2-quinolones","volume":"75","author":"Singh","year":"2019","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2019.103291_b0585","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1021\/acs.joc.7b02498","article-title":"AlCl3-catalyzed intramolecular cyclization of n-arylpropynamides with n-sulfanylsuccinimides: divergent synthesis of 3-sulfenyl quinolin-2-ones and azaspiro[4,5]trienones","volume":"82","author":"Gao","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0590","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1021\/ol0625233","article-title":"enzymatic formation of quinolone alkaloids by a plant type iii polyketide synthase","volume":"8","author":"Abe","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0595","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1055\/s-0036-1588470","article-title":"Easy access to quinolin-2(1H)-ones via a one pot tandem Oxa-Michael-Aldol sequence","volume":"28","author":"Jarriage","year":"2017","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2019.103291_b0600","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1248\/cpb.c17-00035","article-title":"synthesis, molecular docking and biological evaluation of quinolone derivatives as novel anticancer agents, chemical and pharmaceutical bulletin","volume":"66","author":"Li","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2019.103291_b0605","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.bmcl.2017.07.005","article-title":"Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents","volume":"27","author":"Zhou","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0610","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","article-title":"Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives:probing for binding contact with the active site tyrosine of gyrase","volume":"28","author":"Towle","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0615","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1016\/j.bmcl.2013.06.083","article-title":"Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead","volume":"23","author":"Cheng","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0620","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.bmcl.2015.06.068","article-title":"Synthesis and anticancer activity of novel curcumin\u2013quinolone hybrids","volume":"25","author":"Raghavan","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0625","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bmc.2013.11.047","article-title":"Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-ones","volume":"22","author":"Rajput","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00767","article-title":"Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents","volume":"4","author":"Jean","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2019.103291_b0635","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1039\/C8OB90031K","article-title":"Correction: Stereoselective synthesis of natural product inspired carbohydrate fused pyrano[3,2-c]quinolones as antiproliferative agents","volume":"16","author":"Kumari","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0640","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00044-017-1839-4","article-title":"Design and synthesis of three series of novel antitumor\u2013azo derivatives","volume":"26","author":"Lamie","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0645","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejmech.2013.03.011","article-title":"Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening","volume":"63","author":"Suthar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0650","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00044-018-2259-9","article-title":"Synthesis and antitumor activity evaluation of different 2,5-dialkyloxazolopyrano[3,2-c]quinolinone derivatives","volume":"28","author":"Hassanin","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0655","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2019.01.065","article-title":"Quinolone antibiotic derivatives as new selective Axl kinase inhibitors","volume":"166","author":"Tan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0660","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1016\/j.bmc.2016.07.070","article-title":"New antiproliferative 7-(4-(N-substituted carbomoylmethyl) piperazin-1-yl derivatives of ciprofloxacin induce cell cycle arrest at G2\/M phase","volume":"24","author":"Mohammed","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0665","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1248\/cpb.c13-00040","article-title":"Design, synthesis, biological evaluation and molecular docking studies of quinolone derivatives as potential antitumor topoisomerase I inhibitors","volume":"61","author":"Shou","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2019.103291_b0670","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/14756366.2015.1069288","article-title":"Synthesis and potential antitumor activity of 7-(4- substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies","volume":"31","author":"Abdel-Aziz","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0675","first-page":"2308","article-title":"Synthesis, characterization and evaluation of in vitro antitumor activities of novel chalcone-quinolinone hybrid compounds","volume":"29","author":"d\u2019Oliveira","year":"2018","journal-title":"J. Brazil. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103291_b0680","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1007\/s11164-019-03827-y","article-title":"Synthesis of some hybrid 7-hydroxy quinolinone derivatives as anti breast cancer drugs","volume":"45","author":"Moustafa","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2019.103291_b0685","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejmech.2017.09.017","article-title":"Synthesis, structure-activity relationships and preliminary mechanism of action of novel water-soluble 4-quinolone-3-carboxamides as antiproliferative agents","volume":"140","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0690","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0695","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/cpb.c18-00671","article-title":"discovery of novel 7-[(1r,5s)-1-amino-5-fluoro-3-azabicyclo[3.3.0]octan-3-yl]-6-fluoro-1-[(1r,2s)-2-fluorocyclopropane]-8-(methoxy or methyl)quinolones","volume":"67","author":"Komoriya","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2019.103291_b0700","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40199-018-0226-0","article-title":"N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation","volume":"26","author":"Asadipour","year":"2018","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.103291_b0705","first-page":"55","article-title":"Synthesis and study of some new quinolone derivatives containing a 3-acetyl coumarin for their antibacterial and antifungal activities","volume":"16","author":"Valadbeigi","year":"2017","journal-title":"Iranian J. Pharm. Res.: IJPR"},{"key":"10.1016\/j.bioorg.2019.103291_b0710","doi-asserted-by":"crossref","first-page":"42","DOI":"10.31351\/vol21iss2pp42-50","article-title":"synthesis of new coumarin and 2-quinolone derivatives with expected biological activities","volume":"21","author":"Saour","year":"2012","journal-title":"Iraqi J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.103291_b0715","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/14756366.2013.855925","article-title":"Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds","volume":"29","author":"Al-Qawasmeh","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0720","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.saa.2013.09.046","article-title":"Synthesis, spectral features and biological activity of some novel hetarylazo dyes derived from 8-chloro-4-hydroxyl-2-quinolone","volume":"117","author":"Yahyazadeh","year":"2014","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bioorg.2019.103291_b0725","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1016\/j.bmc.2010.06.050","article-title":"Synthesis and biological activity of 4\u2033-O-acyl derivatives of 14- and 15-membered macrolides linked to \u03c9-quinolone-carboxylic unit","volume":"18","author":"\u0160kugor","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0730","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.bmcl.2013.01.048","article-title":"Synthesis and in vitro antibacterial activity of quinolone\/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl)aminopiperidine scaffolds","volume":"23","author":"Lv","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0735","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1007\/s00044-014-1107-9","article-title":"Synthesis and biological evaluation of novel quinolin-2(1H)-one derivatives as potential antimicrobial agents","volume":"23","author":"Deng","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0740","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2014.09.029","article-title":"Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety","volume":"86","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0745","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2015.08.015","article-title":"Discovery of WQ-3810: design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents","volume":"103","author":"Itoh","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0750","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2017.07.004","article-title":"Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents","volume":"138","author":"Abdelrahman","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0755","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jhet.1769","article-title":"different heterocycles functionalized s-triazine analogues: design, synthesis and in vitro antimicrobial, antituberculosis, and anti-hiv assessment","volume":"51","author":"Patel","year":"2014","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0760","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jfluchem.2011.06.021","article-title":"Synthesis, characterization and pharmacological activities of 2-[4-cyano-(3-trifluoromethyl)phenyl amino)]-4-(4-quinoline\/coumarin-4-yloxy)-6-(fluoropiperazinyl)-s-triazines","volume":"132","author":"Patel","year":"2011","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0765","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2019.01.005","article-title":"Synthesis, characterization and biological evaluation of Co(III) complexes with quinolone drugs","volume":"193","author":"Kozsup","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2019.103291_b0770","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1039\/C8MD00480C","article-title":"Quinolone-isoniazid hybrids: synthesis and preliminary in vitro cytotoxicity and anti-tuberculosis evaluation","volume":"10","author":"Beteck","year":"2019","journal-title":"MedChemComm."},{"key":"10.1016\/j.bioorg.2019.103291_b0775","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/molecules24020327","article-title":"Synthesis, in silico, and in vitro evaluation of long chain alkyl amides from 2-amino-4-quinolone derivatives as biofilm inhibitors","volume":"24","author":"Espinosa-Vald\u00e9s","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103291_b0780","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.13005\/ojc\/300462","article-title":"Synthesis, antimicrobial and antitubercular activities of some novel carboxamide derivatives of 2-quinolones","volume":"4","author":"Kumar","year":"2014","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0785","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s10593-009-0384-6","article-title":"4-Hydroxy-2-quinolones. 168*. synthesis, chemical and antitubercular properties of 1-r-4-hydroxy-2-oxo-1, 2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides","volume":"45","author":"Ukrainets","year":"2009","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2019.103291_b0790","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00044-013-0608-2","article-title":"Solvent-free, one-pot synthesis and biological evaluation of some new dipyrazolo [3,4-b:4\u2032,3\u2032-e]pyranylquinolones and their precursors","volume":"23","author":"Parmar","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0795","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.bmcl.2016.08.045","article-title":"One pot Click chemistry: a three component reaction for the synthesis of 2-mercaptobenzimidazole linked coumarinyl triazoles as antitubercular agents","volume":"26","author":"Anand","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0800","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.02.073","article-title":"Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens","volume":"169","author":"Ma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0810","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Fedorowicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0815","first-page":"5296","article-title":"Click chemistry inspired design, synthesis and molecular docking studies of coumarin, quinolinone linked 1,2,3-triazoles as promising anti-microbial agents","volume":"3","author":"Savanur","year":"2018","journal-title":"Chem. Select."},{"key":"10.1016\/j.bioorg.2019.103291_b0820","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00044-019-02372-y","article-title":"New fluoroquinolones\/nitric oxide donor hybrids: design, synthesis and antitubercular activity","volume":"28","author":"Aziz","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103291_b0825","doi-asserted-by":"crossref","first-page":"102965","DOI":"10.1016\/j.bioorg.2019.102965","article-title":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","volume":"88","author":"Ture","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0830","doi-asserted-by":"crossref","first-page":"14204","DOI":"10.3390\/molecules190914204","article-title":"1,2-Substituted 4-(1H)-quinolones: synthesis, antimalarial and antitrypanosomal activities in vitro","volume":"19","author":"Wube","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103291_b0835","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm101439s","article-title":"synthesis and structure\u2013activity relationships of new quinolone-type molecules against trypanosoma brucei","volume":"55","author":"Hiltensperger","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0840","first-page":"987","article-title":"Quinolone amides as anti-trypanosomal lead compounds with in vivo activity","volume":"54","author":"Hiltensperger","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2017","key":"10.1016\/j.bioorg.2019.103291_b0845","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.bmc.2017.06.017","article-title":"Isolation, structure elucidation, and synthesis of antiplasmodial quinolones from Crinum firmifolium","volume":"25","author":"Presley","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0850","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1021\/acs.jmedchem.6b00759","volume":"59","author":"Maignan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0855","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.bmcl.2016.05.024","article-title":"Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities","volume":"26","author":"Beteck","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0860","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/14756366.2014.970185","article-title":"7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits\u03b1-carbonic anhydrases without hydrolysis of the lactam ring","volume":"30","author":"Vullo","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0865","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14756366.2017.1337759","article-title":"Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives","volume":"32","author":"Bozdag","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0870","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10593-011-0692-5","article-title":"4-Hydroxy-2-quinolones. 194*. 1-Hydroxy-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid alkylamides. Synthesis, structure, and biological properties","volume":"46","author":"Ukrainets","year":"2011","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2019.103291_b0875","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bioorg.2018.03.017","article-title":"Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids","volume":"78","author":"Mermer","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0880","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejmech.2016.05.062","article-title":"Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives","volume":"121","author":"Manetti","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0885","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11094-019-1908-8","article-title":"Modification of the benzene moiety in the quinolone nucleus of 4-hydroxy-6,7-dimethoxy-2-oxo-n-(pyridin-3-ylmethyl)-1,2-dihydroquinoline-3-carboxamide as an attempt to enhance its analgesic activity","volume":"52","author":"Ukrainets","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2019.103291_b0890","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.bmc.2014.02.046","article-title":"Quinolone\u2013benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease","volume":"22","author":"Pudlo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0895","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.bmcl.2012.04.096","article-title":"Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity","volume":"22","author":"Suchaud","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103291_b0900","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1021\/acs.jmedchem.8b01467","article-title":"6-Benzhydryl-4 amino-quinolin-2-ones as potent cannabinoid type 1 (CB1) receptor inverse agonists and chemical modifications for peripheral selectivity","volume":"61","author":"Zhang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103291_b0905","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bmc.2016.08.051","article-title":"Discovery and structure-activity relationship studies of quinolinone derivatives as potent IL-2 suppressive agents","volume":"24","author":"Kwak","year":"2016","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819308016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819308016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:02:27Z","timestamp":1758614547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819308016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":183,"alternative-id":["S0045206819308016"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103291","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the synthetic and medicinal perspective of quinolones: A review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103291"}}